Product NDC: | 65862-023 |
Proprietary Name: | Mirtazapine |
Non Proprietary Name: | Mirtazapine |
Active Ingredient(s): | 45 mg/1 & nbsp; Mirtazapine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65862-023 |
Labeler Name: | Aurobindo Pharma Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077376 |
Marketing Category: | ANDA |
Start Marketing Date: | 20060228 |
Package NDC: | 65862-023-06 |
Package Description: | 5 BLISTER PACK in 1 CARTON (65862-023-06) > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
NDC Code | 65862-023-06 |
Proprietary Name | Mirtazapine |
Package Description | 5 BLISTER PACK in 1 CARTON (65862-023-06) > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
Product NDC | 65862-023 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Mirtazapine |
Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
Route Name | ORAL |
Start Marketing Date | 20060228 |
Marketing Category Name | ANDA |
Labeler Name | Aurobindo Pharma Limited |
Substance Name | MIRTAZAPINE |
Strength Number | 45 |
Strength Unit | mg/1 |
Pharmaceutical Classes |